Published in Immunotherapy Weekly, May 26th, 2004
Researchers in England had "previously shown that human CD3-CD56+ and CD3+CD56+ cells from some individuals mount vigorous proliferative responses to lipopolysaccharide.
"Such responses have been blocked by the presence of cytotoxic T-lymphocyte antigen-4 immunoglobulin fusion protein in the cultures, implicating a role for B7-mediated costimulation," according to M.R. Goodier and coauthors at Chelsea and Westminster Hospital in London. In their subsequent study, the collaborators confirmed "this inhibition of natural killer (NK)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.